Showing 1431-1440 of 23116 results for "".
Communicating Drug Safety Messages
https://reachmd.com/programs/FDA-Drug-Information-Updates/communicating-drug-safety-messages/7226/Pharmacists have consistently partnered with FDA on drug safety. Since pharmacists are the most accessible health care professional, they play a key role in educating and discussing FDA's drug safety messages with patients. Moreover, pharmacists are the main reporters of adverse events, incidents ofRecalibrating Meaningful Use Requirements for Better Clinical Adherence
https://reachmd.com/programs/conversations-on-health-care/recalibrating-meaningful-use-requirements-for-better-clinical-adherence/7208/This week, Mark and Margaret speak with Dr. Peter Basch, a Senior Fellow for Health IT Policy with the Center for American Progress, and a Visiting Scholar with the Engelberg Center for Health Care Reform of the Brookings Institution. He represents the American College of Physicians at the PhysicianThe Need to Preserve Beta Cell Function Early
https://reachmd.com/programs/diabetes-discourse/the-need-to-preserve-beta-cell-function-early/5858/New information on the state of impaired glucose tolerance indicates that the level of beta cell loss is greater than once considered. New treatment regimens are being considered to combat both the insulin sensitivity and beta cell loss for type 2 diabetes. What do health care professionals need toInternational Adoption and family travel
https://reachmd.com/programs/clinicians-roundtable/international-adoption-and-family-travel/1370/Your patient is planning to adopt a baby from China? What medical advice can you give her? What can she expect in terms of health exams for the baby? Another aspect of family travel is travel oversees with small children? What are some of their health issues with these long trips? Learn the answCurative Strategies for Sickle Cell Disease: The Future of Gene Editing
https://reachmd.com/programs/project-oncology/curative-strategies-for-sickle-cell-disease-the-future-of-gene-editing/36489/With two FDA-approved gene therapies, including the first CRISPR-based treatment, curative strategies for sickle cell disease are continuing to expand the treatment landscape. However, challenges remain in optimizing safety and accessibility, particularly for patients unable to tolerate current myelCRISPR in Sickle Cell: Transforming Care Through Gene Editing
https://reachmd.com/programs/project-oncology/crispr-in-sickle-cell-transforming-care-through-gene-editing/36233/CRISPR technology, while relatively new, has shown potential in treating patients with sickle cell disease by increasing fetal hemoglobin. Though this gene therapy comes with safety considerations, refinements and advancements in CRISPR technology can offer new management options for sickle cell disPreventive Care Essentials for Patients with IBD: Reviewing ACG Guideline Updates
https://reachmd.com/programs/gi-insights/program-name/36500/A 2025 update to the American College of Gastroenterology (ACG)'s guideline on preventive care in inflammatory bowel disease (IBD) includes key changes impacting vaccine recommendations, dermatologic screening, and care coordination. Dr. Peter Buch sits down with Dr. Francis Farraye, lead author ofScaling Success: Hypertension Control at MPCA with the AMA MAP™ Program
https://reachmd.com/programs/perspectives-ama/scaling-success-hypertension-control-at-mpca-with-the-ama-maptm-program/33009/The Michigan Primary Care Association (MPCA) recently partnered with the AMA to implement the AMA MAP™ Hypertension Quality Improvement Program at two pilot health centers. After this collaboration resulted in a 6 percent improvement in hypertension control, it’s now expanding to all other MPCA healAdvancing Health Information Technology Worldwide
https://reachmd.com/programs/conversations-on-health-care/advancing-health-information-technology-worldwide/6866/This week, hosts Mark Masselli and Margaret Flinter speak with Steve Lieber, President and CEO of the Healthcare Information and Management Systems Society (HIMSS). Historically, HIMSS annually hosts the world's largest health IT educational conference and trade show, attracting over 32,000 healthcMAPLE-HCM Results: Favorable Safety and Efficacy for Aficamten in oHCM
https://reachmd.com/clinical-practice/cardiology/maple-hcm-results-favorable-safety-and-efficacy-for-aficamten-in-ohcm/37255/Dr. Garcia shares the latest data from the MAPLE-HCM trial of aficamten compared with metoprolol in patients with oHCM. Tune in to hear the significance.